Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT06259253
  4. Details
NCT06259253 Clinical Trial

Understanding Patient Experience Among Asians at MD Anderson

Cancer Clinical Trial

Official title:
Understanding Patient Experience Among Asians at MD Anderson

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06259253
Other study ID # 2023-0521
Secondary ID NCI-2024-00901
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2024
Est. completion date July 1, 2030

Study information
Verified date April 2024
Source M.D. Anderson Cancer Center
Contact Lorna McNeill, MPH,PHD
Phone (713) 563-1103
Email lmcneill@mdanderson.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this research study is to understand barriers to and facilitators of a positive patient experience for Asian patients.

Description:

Primary Objective: a. Identify critical aspects of inpatient experience among former Asian/Asian American patients at MD Anderson. Secondary Objectives: a. Determine MD Anderson health care providers' perceptions of Asian/Asian American inpatient experience.

Recruitment information / eligibility
Status Recruiting
Enrollment 520
Est. completion date July 1, 2030
Est. primary completion date July 1, 2030
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria for former patients: - Self-identify as Asian/Asian American - Are 18 years or older - Have been diagnosed with cancer, any type - Received inpatient care at MD Anderson between 2019 and 2022 - Have a U.S. address - Can read and write in English or simplified Chinese Exclusion criteria for former patients: • None Inclusion criteria for healthcare providers: - Self-report as a practicing inpatient provider (advanced practice provider, hospitalist, physician, nurse) at MD Anderson - Treated patients diagnosed with breast, colon, prostate, thyroid, or lymphatic cancer - Provided treatment services to Asian/Asian American patients between 2019 and 2022 Exclusion criteria for healthcare providers: • None

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States MD Anderson Cancer Center Houston Texas

Sponsors (1)
Lead Sponsor Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Picker Patient Experience Questionnaire (PPE-15) Through study completion; an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients

External Links